# Sandridge Energy Inc: financial statements, quarterly

SD · NYSE · CIK 1349436 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sd.md) · [Financials](/companies/sd/financials.md) · [Filings](/companies/sd/filings.md) · [Insiders](/companies/sd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [38.1](/filings/0001628280-24-046378.md) | [33.9 d](/filings/0001628280-26-015318.md) | [30.3](/filings/0001628280-25-023900.md) | [26.0](/filings/0001628280-25-038954.md) | [30.1](/filings/0001628280-25-050313.md) | [39.0 d](/filings/0001628280-26-015318.md) | [42.6](/filings/0001628280-26-032222.md) | [34.5](/filings/0001628280-26-054413.md) | [39.8](/filings/0001628280-25-050313.md) | [39.4 d](/filings/0001628280-26-015318.md) | [49.8](/filings/0001628280-26-032222.md) | [51.1](/filings/0001628280-26-054413.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [16.2](/filings/0001628280-24-046378.md) | [13.0 d](/filings/0001628280-26-015318.md) | [8.4](/filings/0001628280-25-023900.md) | [6.2](/filings/0001628280-25-038954.md) | [8.5](/filings/0001628280-25-050313.md) | [10.1 d](/filings/0001628280-26-015318.md) | [12.2](/filings/0001628280-26-032222.md) | [18.5](/filings/0001628280-26-054413.md) | [15.0](/filings/0001628280-25-050313.md) | [15.2 d](/filings/0001628280-26-015318.md) | [17.9](/filings/0001628280-26-032222.md) | [26.0](/filings/0001628280-26-054413.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001628280-24-046378.md) | [14.0 d](/filings/0001628280-26-015318.md) | [0.0](/filings/0001628280-25-023900.md) | [0.0](/filings/0001628280-25-038954.md) | [(15.4)](/filings/0001628280-25-050313.md) | [(6.8) d](/filings/0001628280-26-015318.md) | [0.0](/filings/0001628280-26-032222.md) | [0.0](/filings/0001628280-26-054413.md) | [0.0](/filings/0001628280-25-050313.md) | [(5.5) d](/filings/0001628280-26-015318.md) | [0.0](/filings/0001628280-26-032222.md) | [0.0](/filings/0001628280-26-054413.md) |
| Net income | $m | [18.7](/filings/0001628280-24-046378.md) | [1.8 d](/filings/0001628280-26-015318.md) | [11.1](/filings/0001628280-25-050313.md) | [8.8](/filings/0001628280-25-050313.md) | [25.5](/filings/0001628280-25-050313.md) | [17.6 d](/filings/0001628280-26-015318.md) | [13.0](/filings/0001628280-26-054413.md) | [19.6](/filings/0001628280-26-054413.md) | [16.0](/filings/0001628280-25-050313.md) | [21.6 d](/filings/0001628280-26-015318.md) | [18.7](/filings/0001628280-26-054413.md) | [26.7](/filings/0001628280-26-054413.md) |
| Diluted EPS | $ per share | [0.50](/filings/0001628280-24-046378.md) | not reported | [0.30](/filings/0001628280-25-023900.md) | [0.24](/filings/0001628280-25-038954.md) | [0.69](/filings/0001628280-25-050313.md) | not reported | [0.35](/filings/0001628280-26-032222.md) | [0.53](/filings/0001628280-26-054413.md) | [0.43](/filings/0001628280-25-050313.md) | not reported | [0.50](/filings/0001628280-26-032222.md) | [0.72](/filings/0001628280-26-054413.md) |
| Basic EPS | $ per share | [0.51](/filings/0001628280-24-046378.md) | not reported | [0.30](/filings/0001628280-25-023900.md) | [0.24](/filings/0001628280-25-038954.md) | [0.69](/filings/0001628280-25-050313.md) | not reported | [0.35](/filings/0001628280-26-032222.md) | [0.53](/filings/0001628280-26-054413.md) | [0.44](/filings/0001628280-25-050313.md) | not reported | [0.51](/filings/0001628280-26-032222.md) | [0.72](/filings/0001628280-26-054413.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [231](/filings/0001628280-23-037414.md) | [252](/filings/0001628280-26-015318.md) | [207](/filings/0001628280-24-021771.md) | [210](/filings/0001628280-24-036244.md) | [92.7](/filings/0001628280-24-046378.md) | [98.1](/filings/0001628280-26-015318.md) | [99.7](/filings/0001628280-25-023900.md) | [103](/filings/0001628280-25-038954.md) | [101](/filings/0001628280-25-050313.md) | [111](/filings/0001628280-26-054413.md) | [103](/filings/0001628280-26-032222.md) | [113](/filings/0001628280-26-054413.md) |
| Current assets | $m | [260](/filings/0001628280-23-037414.md) | [278](/filings/0001628280-25-012086.md) | [234](/filings/0001628280-24-021771.md) | [237](/filings/0001628280-24-036244.md) | [126](/filings/0001628280-24-046378.md) | [128](/filings/0001628280-26-015318.md) | [131](/filings/0001628280-25-023900.md) | [136](/filings/0001628280-25-038954.md) | [137](/filings/0001628280-25-050313.md) | [148](/filings/0001628280-26-054413.md) | [143](/filings/0001628280-26-032222.md) | [152](/filings/0001628280-26-054413.md) |
| Total assets | $m | [577](/filings/0001628280-23-037414.md) | [574](/filings/0001628280-25-012086.md) | [527](/filings/0001628280-24-021771.md) | [530](/filings/0001628280-24-036244.md) | [565](/filings/0001628280-24-046378.md) | [582](/filings/0001628280-26-015318.md) | [588](/filings/0001628280-25-023900.md) | [602](/filings/0001628280-25-038954.md) | [619](/filings/0001628280-25-050313.md) | [644](/filings/0001628280-26-054413.md) | [652](/filings/0001628280-26-032222.md) | [668](/filings/0001628280-26-054413.md) |
| Current liabilities | $m | [55.2](/filings/0001628280-23-037414.md) | [49.3](/filings/0001628280-25-012086.md) | [49.8](/filings/0001628280-24-021771.md) | [46.2](/filings/0001628280-24-036244.md) | [58.8](/filings/0001628280-24-046378.md) | [60.6](/filings/0001628280-26-015318.md) | [61.6](/filings/0001628280-25-023900.md) | [59.2](/filings/0001628280-25-038954.md) | [62.9](/filings/0001628280-25-050313.md) | [68.0](/filings/0001628280-26-054413.md) | [59.5](/filings/0001628280-26-032222.md) | [57.8](/filings/0001628280-26-054413.md) |
| Total liabilities | $m | [108](/filings/0001628280-23-037414.md) | [106](/filings/0001628280-25-012086.md) | [108](/filings/0001628280-24-021771.md) | [105](/filings/0001628280-24-036244.md) | [118](/filings/0001628280-24-046378.md) | [121](/filings/0001628280-26-015318.md) | [123](/filings/0001628280-25-023900.md) | [122](/filings/0001628280-25-038954.md) | [127](/filings/0001628280-25-050313.md) | [133](/filings/0001628280-26-054413.md) | [126](/filings/0001628280-26-032222.md) | [125](/filings/0001628280-26-054413.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [470](/filings/0001628280-23-037414.md) | [468](/filings/0001628280-25-012086.md) | [420](/filings/0001628280-24-021771.md) | [425](/filings/0001628280-24-036244.md) | [447](/filings/0001628280-24-046378.md) | [461](/filings/0001628280-26-054413.md) | [465](/filings/0001628280-26-054413.md) | [480](/filings/0001628280-26-054413.md) | [492](/filings/0001628280-25-050313.md) | [511](/filings/0001628280-26-054413.md) | [526](/filings/0001628280-26-054413.md) | [543](/filings/0001628280-26-054413.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.5 d](/filings/0001628280-24-046378.md) | [26.2 d](/filings/0001628280-26-015318.md) | [15.7](/filings/0001628280-25-023900.md) | [11.4 d](/filings/0001628280-25-038954.md) | [20.8 d](/filings/0001628280-25-050313.md) | [26.0 d](/filings/0001628280-26-015318.md) | [20.3](/filings/0001628280-26-032222.md) | [22.9 d](/filings/0001628280-26-054413.md) | [25.3 d](/filings/0001628280-25-050313.md) | [31.7 d](/filings/0001628280-26-015318.md) | [19.8](/filings/0001628280-26-032222.md) | [42.4 d](/filings/0001628280-26-054413.md) |
| Capital expenditure | $m | [1.4 d](/filings/0001628280-24-046378.md) | [0.7 d](/filings/0001628280-26-015318.md) | [1.1](/filings/0001628280-25-023900.md) | [2.5 d](/filings/0001628280-25-038954.md) | [10.0 d](/filings/0001628280-25-050313.md) | [12.8 d](/filings/0001628280-26-015318.md) | [6.4](/filings/0001628280-26-032222.md) | [15.6 d](/filings/0001628280-26-054413.md) | [19.4 d](/filings/0001628280-25-050313.md) | [17.3 d](/filings/0001628280-26-015318.md) | [20.9](/filings/0001628280-26-032222.md) | [19.2 d](/filings/0001628280-26-054413.md) |
| Dividends paid | $m | [4.0 d](/filings/0001628280-24-046378.md) | [3.7 d](/filings/0001628280-26-015318.md) | [59.7](/filings/0001628280-25-023900.md) | [4.3 d](/filings/0001628280-25-038954.md) | [4.2 d](/filings/0001628280-25-050313.md) | [4.1 d](/filings/0001628280-26-015318.md) | [4.1](/filings/0001628280-26-054413.md) | [4.1](/filings/0001628280-26-054413.md) | [3.8 d](/filings/0001628280-25-050313.md) | [3.9 d](/filings/0001628280-26-015318.md) | [3.9](/filings/0001628280-26-054413.md) | [10.6](/filings/0001628280-26-054413.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0001628280-25-023900.md) | [0.0 d](/filings/0001628280-25-038954.md) | [0.0 d](/filings/0001628280-25-050313.md) | [0.2 d](/filings/0001628280-26-015318.md) | [5.0](/filings/0001628280-26-032222.md) | [0.9 d](/filings/0001628280-26-054413.md) | [0.5 d](/filings/0001628280-25-050313.md) | [0.0 d](/filings/0001628280-26-015318.md) | [0.0](/filings/0001628280-26-032222.md) | [0.0 d](/filings/0001628280-26-054413.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.2](/filings/0001628280-23-037414.md) | [37.1](/filings/0001628280-24-021771.md) | [37.1](/filings/0001628280-24-036244.md) | [37.2](/filings/0001628280-24-046378.md) | [37.1](/filings/0001628280-25-023900.md) | [37.2](/filings/0001628280-25-038954.md) | [37.2](/filings/0001628280-25-050313.md) | [37.1](/filings/0001628280-26-032222.md) | [36.7](/filings/0001628280-26-054413.md) | [36.7](/filings/0001628280-25-050313.md) | [37.0](/filings/0001628280-26-032222.md) | [37.1](/filings/0001628280-26-054413.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 37,075,296 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054413.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.